tiprankstipranks
Akero Therapeutics Inc (AKRO)
NASDAQ:AKRO

Akero Therapeutics (AKRO) Balance Sheet

424 Followers

Akero Therapeutics Balance Sheet

Akero Therapeutics's total assets for Q4 2023 were $580.27M, a decrease of -8.67% from the previous quarter. AKRO total liabilities were $44.97M for the fiscal quarter, a -13.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 580.27M$ 356.57M$ 195.55M$ 273.34M$ 138.12M
Total Liabilities
$ 44.97M$ 30.01M$ 26.44M$ 14.63M$ 9.39M
Total Equity Gross Minority
$ 535.31M$ 326.56M$ 169.11M$ 258.71M$ 128.73M
Total Capitalization
$ 586.05M$ 336.10M$ 169.11M$ 258.71M$ 128.73M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 1.81M$ 85.00K
Currency in USD

Akero Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis